Niagen Bioscience (NAGE) Receivables - Other (2016 - 2023)
Historic Receivables - Other for Niagen Bioscience (NAGE) over the last 11 years, with Q1 2023 value amounting to $3.5 million.
- Niagen Bioscience's Receivables - Other rose 5217.39% to $3.5 million in Q1 2023 from the same period last year, while for Mar 2023 it was $3.5 million, marking a year-over-year increase of 5217.39%. This contributed to the annual value of $3.1 million for FY2022, which is 4761.9% up from last year.
- Latest data reveals that Niagen Bioscience reported Receivables - Other of $3.5 million as of Q1 2023, which was up 5217.39% from $3.1 million recorded in Q4 2022.
- Niagen Bioscience's Receivables - Other's 5-year high stood at $3.5 million during Q1 2023, with a 5-year trough of $800000.0 in Q4 2019.
- For the 5-year period, Niagen Bioscience's Receivables - Other averaged around $1.7 million, with its median value being $1.6 million (2019).
- Its Receivables - Other has fluctuated over the past 5 years, first soared by 15265.96% in 2019, then plummeted by 4736.84% in 2020.
- Niagen Bioscience's Receivables - Other (Quarter) stood at $800000.0 in 2019, then rose by 12.5% to $900000.0 in 2020, then surged by 133.33% to $2.1 million in 2021, then surged by 47.62% to $3.1 million in 2022, then grew by 12.9% to $3.5 million in 2023.
- Its Receivables - Other stands at $3.5 million for Q1 2023, versus $3.1 million for Q4 2022 and $2.4 million for Q3 2022.